HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel neurotrophic tyrosine kinase receptor type 1 gene mutation associated with congenital insensitivity to pain with anhidrosis.

Abstract
Congenital insensitivity to pain with anhidrosis (hereditary sensory and autonomic neuropathy type IV) is a rare autosomal recessive disorder caused by a defect in neurotrophic tyrosine kinase receptor and nerve growth factor, as reported in previous studies. This report is of a 6-month-old male infant with typical symptoms and signs of congenital insensitivity to pain with anhidrosis. He had a homozygous insertion mutation with c.2086_2087 ins C of neurotrophic tyrosine kinase receptor type 1 (NTRK1) gene with both parents as heterozygous carriers. This mutation may have a strong relation to hereditary sensory and autonomic neuropathy type IV Taiwanese patients. This is the youngest reported patient in Taiwan and first reported with congenital insensitivity to pain with mutation of NTRK1 gene inherited from the parents. Early diagnosis may provide appropriate medical care and education for these children and their families for better prognosis.
AuthorsYi-Pei Lin, Yi-Ning Su, Wen-Chin Weng, Wang-Tso Lee
JournalJournal of child neurology (J Child Neurol) Vol. 25 Issue 12 Pg. 1548-51 (Dec 2010) ISSN: 1708-8283 [Electronic] United States
PMID20647579 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Receptor, trkA
Topics
  • Age of Onset
  • Asian People (ethnology, genetics)
  • DNA Mutational Analysis (methods)
  • Genetic Predisposition to Disease (genetics)
  • Genetic Testing (methods)
  • Genotype
  • Hereditary Sensory and Autonomic Neuropathies (enzymology, genetics)
  • Humans
  • Infant
  • Male
  • Mutation (genetics)
  • Receptor, trkA (genetics)
  • Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: